EBV cell subtype in EBV-HLH and CAEBV
Patient . | Source . | EBV subtype . | ||
---|---|---|---|---|
LMP-1 . | EBNA-1 . | EBNA-2 . | ||
EBV-HLH1 | CD8+ T cell | Del | P-Ala, V-Val | NA |
sLCL | Del | V-Val | Type A | |
EBV-HLH2 | PBMNC | Del | NA | Type A |
T cell | Del | V-Val | Type A | |
Non–T cell | Del | P-Ala, V-Val | Type A | |
EBV-HLH3 | PBMNC | Del | NA | NA |
sLCL | Del | V-Val | Type A | |
EBV-HLH4 | CD8+T cell | Del | V-Val | Type A |
CD16+ NK cell | Del | P-Ala, V-Val | Type A | |
CD20+ B cell | Del | V-Val | NA | |
sLCL | Del | V-Val | Type A | |
CAEBV1 | CD4+ T cell | Del | V-Val | Type A |
CD8+ T cell | Del | V-Val | Type A | |
CAEBV2 | PBMNC | Del | V-Val | Type A |
CD16+NK cell | Del | V-Val | Type A | |
CAEBV3 | CD4+ T cell | Del | V-Val | Type A |
sLCL | Del | V-Val | Type A | |
CAEBV4 | PBMNC | Wild | P-Ala | Type A |
Patient . | Source . | EBV subtype . | ||
---|---|---|---|---|
LMP-1 . | EBNA-1 . | EBNA-2 . | ||
EBV-HLH1 | CD8+ T cell | Del | P-Ala, V-Val | NA |
sLCL | Del | V-Val | Type A | |
EBV-HLH2 | PBMNC | Del | NA | Type A |
T cell | Del | V-Val | Type A | |
Non–T cell | Del | P-Ala, V-Val | Type A | |
EBV-HLH3 | PBMNC | Del | NA | NA |
sLCL | Del | V-Val | Type A | |
EBV-HLH4 | CD8+T cell | Del | V-Val | Type A |
CD16+ NK cell | Del | P-Ala, V-Val | Type A | |
CD20+ B cell | Del | V-Val | NA | |
sLCL | Del | V-Val | Type A | |
CAEBV1 | CD4+ T cell | Del | V-Val | Type A |
CD8+ T cell | Del | V-Val | Type A | |
CAEBV2 | PBMNC | Del | V-Val | Type A |
CD16+NK cell | Del | V-Val | Type A | |
CAEBV3 | CD4+ T cell | Del | V-Val | Type A |
sLCL | Del | V-Val | Type A | |
CAEBV4 | PBMNC | Wild | P-Ala | Type A |
EBV subtype was estimated from DNA isolated from indicated cell populations by PCR methods and sequencing of PCR products.
Del indicates 30-bp deletion at C-terminal of LMP-1; NA, not amplified by PCR; sLCL, spontaneously growing EBV+ lymphoblastoid B-cell line.